| |
| |
|
| Insider
Information: |
Sato Vicki L |
| Relationship: |
|
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
1,672,571 |
|
|
Indirect Shares
|
8,084 |
|
|
| Direct
Value |
$36,205,289 |
|
|
|
Indirect Value
|
$3,213,228 |
|
|
| Total
Shares |
1,680,655 |
|
|
| Total
Value |
$39,418,517 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
President |
2005-05-11 |
77,233 |
2005-05-11 |
8,084 |
Premium* |
|
|
Perkinelmer Inc |
PKI |
Director |
2017-02-09 |
29,970 |
2004-04-27 |
0 |
Premium* |
|
|
Infinity Pharmaceuticals Inc |
INFI |
Director |
2006-09-12 |
11,051 |
2006-09-12 |
0 |
Premium* |
|
|
Borgwarner Inc |
BWA |
Director |
2020-04-29 |
19,823 |
2014-04-30 |
0 |
Premium* |
|
|
Denali Therapeutics Inc. |
DNLI |
Director |
2024-04-15 |
118,043 |
2017-12-12 |
0 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2023-06-30 |
1,315,351 |
|
0 |
Premium* |
|
|
Allogene Therapeutics, Inc. |
ALLO |
|
2023-06-13 |
101,100 |
2021-07-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
226 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 10
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2019-10-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,669,110 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
President |
• – – |
2003-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
135,917 |
|
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2005-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
3,020 |
14,232 |
|
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2006-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,770 |
17,002 |
|
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Director |
– • – |
2006-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
11,051 |
11,051 |
|
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2007-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,114 |
21,116 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2008-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
3,740 |
24,856 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2009-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
5,790 |
30,646 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2011-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,544 |
38,527 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2012-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,580 |
42,107 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2013-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,263 |
45,370 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2014-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,373 |
47,743 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2015-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
3,033 |
26,776 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2016-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,194 |
29,970 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2017-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
62,500 |
137,500 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2021-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,374 |
1,657,310 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,074 |
136,163 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
|
– • – |
2021-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
19,362 |
19,362 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2022-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
6,405 |
1,509,868 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2022-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
5,986 |
142,149 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
|
– • – |
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
22,089 |
41,451 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2023-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,027 |
1,333,351 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,216 |
136,369 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
|
• • – |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
59,649 |
101,100 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
President |
• – – |
2004-05-06 |
4 |
A |
$0.01 |
$875 |
D/D |
87,500 |
188,108 |
|
- |
|
226 Records found
|
|
Page 1 of 10 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
